8 December 2021 in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Purpose:to identify factors influencing the results of health technology assessment (HTA).Methods.This analysis is based on previously performed clinical (pharmaco-) economic studies in the Republic of Belarus. The primary data analysis methods for inclusion in this publication have been cost-of-illness analysis (COI). The studies were carried out from 2010 to 2021. All costs are presented in US dollars based on exchange rates at the time of execution. Ranges are presented as maximum and minimum values.Results.The analysis of the influence of the stage of the disease, the stage of medical care, the form of release for drugs, the age of the target population for the use of health technology, the source of information on the price of technology on the results of the procedure for assessing medical technology has been performed. Evaluation of the ratio of the results of COI for implementation the clinical protocol and capabilities of the healthcare system (stable angina pectoris, type 2 diabetes mellitus), as well as for a number of special health technologies (hemophilia A; post-stroke spasticity; mantle cell lymphoma; chronic lymphocytic leukemia; chronic myeloid leukemia; lung cancer).Conclusions.It can be concluded that there is a need for clear formulations of goals and objectives at the stage of formation of the study design, considering the influence of the position of the researcher, the source of costs, the selected population, form of release (for drugs) on the main clinical and economic indicators and on the subsequent interpretation of the results of HTA.
20 March 2025 in Journal of Health Development
Improving the quality of management of antimicrobial therapy as a medical technology in healthcare settings is one of the main goals of the World Health Organization's global plan to combat antimicrobial resistance. As part of this activity, it is relevant to search for and implement into practice effective methods for analyzing the consumption of this group of drugs.The purpose of this study is to determine the place of the AWaRe classification in the development of local antimicrobial therapy management programs.Methods. ABC/VEN analysis and DDD (ATC/DDD methodology) were used to analyze the consumption of antimicrobial drugs. The consumption of antibacterial drugs was analyzed using the AWaRe method, 2023, based on the DDD and the WHO list of main antibiotics by groups: “Access” (A), “Watch” (W), “Reserve” (R), “Not recommended” (N). Statistical processing of the results was carried out using descriptive statistics methods using the MS Office EXCEL 2016 program.Results. An analysis of antibiotic consumption in four multidisciplinary hospitals in Minsk for 2022 and 2023 was carried out using pharmacoepidemiological DDD methodology and AWaRe classification. The study determined the place of this tool in the development ofantibacterial therapy management programs.Conclusions. The study noted that the use of the AWaRe classification as part of the development of an antibacterial therapy management program can complement the niche of descriptive data analytics, that is, it will make it possible to describe the structure of consumption of antibacterial drugs using a formalized, stereotypical international tool. This tool further provides an opportunity to implement diagnostic tasksto develop measures to influence the policy and practice of using antibacterial drugs.
9 November 2023 in Кардиология в Беларуси